Milsaperidone is an atypical antipsychotic agent primarily utilized for the treatment of schizophrenia in adults, as well as the management of acute manic or mixed episodes associated with bipolar I disorder.… Read more
Milsaperidone is an atypical antipsychotic agent primarily utilized for the treatment of schizophrenia in adults, as well as the management of acute manic or mixed episodes associated with bipolar I disorder. Functioning as a dopamine D2 receptor antagonist with serotonin 5-HT2A antagonistic activity, it modulates neurotransmission within the central nervous system. This category provides essential reference standards for Milsaperidone, including its active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These high-quality materials are critical for researchers and analytical chemists conducting impurity profiling, method validation, and rigorous quality control protocols. By providing structurally verified compounds, these reference standards ensure accurate identification and quantification during the development and regulatory testing of this pharmaceutical substance, supporting compliance with established pharmacopeial requirements.